-+ 0.00%
-+ 0.00%
-+ 0.00%

NeuroSense Therapeutics Announces Positive Phase 2b Results for PrimeC, Showing Significant Reduction in Alzheimer’s Disease Biomarkers

Reuters·10/06/2025 13:00:57

Please log in to view news